Association study between the DAT1, DBH and DRD2 genes and cocaine dependence in a Spanish sample.
- Authors
- Fernàndez-Castillo, Noèlia; Ribasés, Marta; Roncero, Carlos; Casas, Miquel; Gonzalvo, Begoña; Cormand, Bru
- Year
- 2010
- Journal
- Psychiatric genetics
- PMID
- 20505554
- DOI
- 10.1097/YPG.0b013e32833b6320
Drug addiction is a complex neuropsychiatric disorder involving the environmental and genetic factors. Genetic and physiological evidences suggest that the dopaminergic system may play an important role in cocaine abuse and dependence. Several association studies have focused on dopaminergic genes. We genotyped the Int8 and 3'UTR variable number of tandem repeats of the dopamine transporter gene (DAT1/SLC6A3), the TaqIA (rs1800497) and TaqIB (rs1079597) SNP polymorphisms within the dopamine receptor D2 gene and the 19-bp insertion/deletion and c.444G>A (rs1108580) polymorphisms of the dopamine β-hydroxylase gene (DBH) in a Spanish sample of 169 patients with cocaine addiction and 169 sex-matched controls. The case-control study showed a nominal overrepresentation of the 5R/5R genotype of the Int8 variable number of tandem repeats within DAT1 in cocaine abusers (P=0.016). However, no significant associations were detected when DAT1 haplotype frequencies or polymorphisms within the other dopaminergic genes were considered. Sample size is limited and further studies should be performed in a larger cohort.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| The aggregate effect of dopamine genes on dependence symptoms among cocaine users: cross-validation of a candidate system scoring approach. | 2012 | 22358648 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Exploring dopamine as the master regulator of brain circuitry and mental health genome. | Blum K et al. | — | 2025 | → |
| Genetic association of SLC6A3 (dopamine transporter) gene polymorphisms with personality disorders and substance abuse disorders: a systematic review and meta-analysis. | Vogiatzoglou AV et al. | — | 2024 | → |
| Single Nucleotide Variants (SNVs) of the Mesocorticolimbic System Associated with Cardiovascular Diseases and Type 2 Diabetes: A Systematic Review. | Merzah M et al. | — | 2024 | → |
| A systems omics-based approach to decode substance use disorders and neuroadaptations. | Veerappa A et al. | — | 2021 | → |
| Genetics of cocaine and methamphetamine consumption and preference in Drosophila melanogaster. | Highfill CA et al. | — | 2019 | → |
| No Influence of Dopamine System Gene Variations on Acute Effects of MDMA. | Vizeli P et al. | — | 2019 | → |
| Pharmacogenetic role of dopamine transporter (SLC6A3) variation on response to disulfiram treatment for cocaine addiction. | Kampangkaew JP et al. | — | 2019 | → |
| A prospective, longitudinal study to evaluate the clinical utility of a predictive algorithm that detects risk of opioid use disorder. | Brenton A et al. | — | 2018 | → |
| Genetics of Cocaine and Methamphetamine Consumption and Preference in<i>Drosophila melanogaster</i> | Highfill CA et al. | — | 2018 | — |
| The dopamine transporter role in psychiatric phenotypes. | Salatino-Oliveira A et al. | — | 2018 | → |
| Association between the Intron 8 VNTR Polymorphism of the DAT1 Gene and Crack Cocaine Addiction. | Stolf AR et al. | — | 2017 | → |
| Observational study to calculate addictive risk to opioids: a validation study of a predictive algorithm to evaluate opioid use disorder. | Brenton A et al. | — | 2017 | → |
| Validation Study of a Predictive Algorithm to Evaluate Opioid Use Disorder in a Primary Care Setting. | Sharma M et al. | — | 2017 | → |
| Adding Genetic Testing to Evidence-Based Guidelines to Determine the Safest and Most Effective Chronic Pain Treatment for Injured Workers. | Meshkin B et al. | — | 2015 | → |
| Association between DRD2/ANKK1 TaqIA polymorphism and common illicit drug dependence: evidence from a meta-analysis. | Deng XD et al. | — | 2015 | → |
| Criteria and Concurrent Validity of Adult ADHD Section of the Psychiatry Research Interview for Substance and Mental Disorders. | Ramos-Quiroga JA et al. | — | 2015 | → |
| Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans. | Levran O et al. | — | 2015 | → |
| Should pathological gambling and obesity be considered addictive disorders? A factor analytic study in a nationally representative sample. | Blanco C et al. | — | 2015 | → |
| Crack cocaine users show differences in genotype frequencies of the 3' UTR variable number of tandem repeats of the dopamine transporter gene (DAT1/SLC6A3). | Stolf AR et al. | — | 2014 | → |
| Lack of association between dopamine-β hydroxylase gene and a history of suicide attempt in schizophrenia: comparison of molecular and statistical haplotype analyses. | Howe AS et al. | — | 2014 | → |
| Association study of 37 genes related to serotonin and dopamine neurotransmission and neurotrophic factors in cocaine dependence. | Fernàndez-Castillo N et al. | — | 2013 | → |
| Butyrylcholinesterase genetic variants: association with cocaine dependence and related phenotypes. | Negrão AB et al. | — | 2013 | → |
| Genetic variants associated with addictive behavior in Colombian addicted and non-addicted to heroin or cocaine. | Isaza C et al. | — | 2013 | → |
| Candidate pathway association study in cocaine dependence: the control of neurotransmitter release. | Fernàndez-Castillo N et al. | — | 2012 | → |
| Obesity and the brain: how convincing is the addiction model? | Ziauddeen H et al. | — | 2012 | → |
| Repeat variation in the human PER2 gene as a new genetic marker associated with cocaine addiction and brain dopamine D2 receptor availability. | Shumay E et al. | — | 2012 | → |
| The aggregate effect of dopamine genes on dependence symptoms among cocaine users: cross-validation of a candidate system scoring approach. | Derringer J et al. | — | 2012 | → |